Table 2.
S. No. | Type of Formulation | Size of NP/Fibres | Microbes | Special Comments | References |
---|---|---|---|---|---|
1. | Bletilla striata (BSP) film | 0.097 ± 0.004 to 0.136 ± 0.003 mm thickness |
Escherichia coli staphylococcus aureus and Pseudomonas aeruginosa |
In this study, the author reported that the prepared BSP/CS films may be used to create biomaterials for new wound dressings. | [81] |
2. | Eucalyptus-oil-loaded chitosan nanofibres | 48.26 nm | Staphylococcus aureus | The developed nano-chitosan/Eucalyptus oil/cellulose acetate nanofibre has excellent antimicrobial properties and shows promise as a wound healing dressing. | [82] |
3. | CSNPs | 141.20 nm | S. aureus and P. aeruginosa | The dose-dependent antibacterial activity was observed. | [83] |
4. | Lecithin-coated CSNPs | 235 ± 20 nm | S. aureus | A 2-fold decrease in the survival rate of S. aureus was observed. | [84] |
5. | CS-AgNPs | 10–30 nm | Methicillin-resistant streptococcus aureus (MRSA) | MRSA was not detected in all treated groups. | [85] |
6. | CSNPs | 408.30 ± 53.17 nm | S. aureus | More than 90% inhibition rate was observed in CSNP-treated groups. | [86] |
7. | AgNPs | - | S. aureus, P. aeruginosa, and E. coli | The prepared sponges loaded with AgNPs show excellent antibacterial activity against S. aureus, P. aeruginosa, and E. coli. | [87] |
8. | CS-AgNPs | 10–50 nm | MRSA and P. aeruginosa | The CS-AgNPs show good antibacterial activity against MRSA and P. aeruginosa. | [88] |
9. | CS-AgNPs | 22.80 nm | E. coli | The CS film loaded with CS-AgNPs showed higher inhibition against E. coli compared to CS-AgNP solution. | [89] |
10. | CS fibres | - | Escherichia coli, Staphylococcus aureus, and Candida albicans | The prepared fibres showed excellent antibacterial activity. | [90] |
11. | CS nanofibres | 140–170 | E. coli and S. aureus | The CS nanofibres loaded with cinnamon extract enhance the antibacterial activity. | [91] |
12. | CSNPs | 208.40 ± 15.70 nm | E. coli and S. aureus | The CSNPs show dose-dependent antibacterial activity and have greater effect against S. aureus than E. coli. | [92] |
13. | CSNPs | 51.67 ± 12.55 nm | S. aureus, P. aeruginosa, E. coli, B. subtilis, and C. albicans | The CSNP loaded with SSD show greater effect against gram +ve bacteria than gram −ve bacteria. | [93] |
14. | AgNPs | 5–10 nm | Staphylococcus aureus and Pseudomonas aeruginosa | The 3D scaffold loaded with AgNPs showed excellent antibacterial activity. | [94] |
E. coli—Escherichia coli; S. aureus—Staphylococcus aureus; C. albicans—Candida albicans; SSD—silver sulfadiazine; CS—chitosan; AgNPs—silver nanoparticles; MRSA—Methicillin-resistant Staphylococcus aureus.